Physician profile
Roddy Cook
NPI 1659358943
$868.44
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $703 · 2020: $165.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $239.51 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $111.27 | 2019-2020 | |
| Amarin Pharma, INC. | $109.17 | 2019 | |
| Glaxosmithkline, LLC. | $79.08 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $60.30 | 2019 | |
| Mylan Specialty L.P. | $60.10 | 2019 | |
| Astellas Pharma US INC | $46.66 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.42 | 2019 | |
| Merck Sharp & Dohme LLC | $23.32 | 2019-2020 | |
| Amgen INC. | $22.98 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $22.87 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $17.80 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.04 | 2019 | |
| Horizon Therapeutics Plc | $13.74 | 2020 | |
| Lilly USA, LLC | $11.18 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roddy Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.